PRKN and esophageal squamous cell carcinoma: The survival curve in our study revealed that patients with ESCC who had low PARK2 expression had a shorter OS, and Cox univariate and multivariate analyses revealed that low PARK2 expression independently predicted the poor OS in ESCC.